TY - JOUR
T1 - Health-related quality of life in children with sickle cell disease
T2 - A report from the comprehensive sickle cell centers clinical trial consortium
AU - Dampier, Carlton
AU - Lieff, Susan
AU - LeBeau, Petra
AU - Rhee, Seungshin
AU - McMurray, Marsha
AU - Rogers, Zora
AU - Smith-Whitley, Kim
AU - Wang, Winfred
PY - 2010/9
Y1 - 2010/9
N2 - Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53% boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68% and 32% had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.
AB - Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53% boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68% and 32% had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.
KW - HRQOL
KW - Peds QL
KW - Sickle cell disease
UR - http://www.scopus.com/inward/record.url?scp=77955486134&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955486134&partnerID=8YFLogxK
U2 - 10.1002/pbc.22497
DO - 10.1002/pbc.22497
M3 - Article
C2 - 20658620
AN - SCOPUS:77955486134
SN - 1545-5009
VL - 55
SP - 485
EP - 494
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 3
ER -